NeuroPointDX

Our first-generation tool, the NeuroPointDX Autism Spectrum Disorder (NPDX ASD) blood test, assists with the diagnosis of autism spectrum disorder. The test measures differences in the metabolism of children associated with an ASD diagnosis in our clinical study, the Children’s Autism Metabolome Project (CAMP). The CAMP study is the largest clinical study to date to evaluate the metabolism of children with ASD and was funded by the U.S. National Institutes of Mental Health (NIMH).

Our mission is to improve the lives of children and families living with ASD by providing tools for earlier diagnosis and more precise treatment. We continue to look for ways to identify more children with ASD and to advise treatment that addresses their specific needs. Please visit our website to learn more about the NPDX ASD blood test, how to get your child tested, and how to participate in our next study.

We are located in University Research Park, in Madison, Wisconsin, USA.